Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

418
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
418
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

176
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
176
Cancer Prevention02:59

Cancer Prevention

6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The current molecular landscape of endometrial and ovarian carcinomas: insights and practical updates.

Seminars in diagnostic pathology·2026
Same author

Clinical impact of second opinion consultation in bladder biopsies and transurethral resection of bladder tumors.

Human pathology·2026
Same author

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same author

Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors.

Human pathology·2026
Same author

Non-governmental organisations and the regulation of harmful commodity industries: navigating global governance to change corporate practices.

Globalization and health·2026
Same author

From endorsement of the WHO Acceleration Plan to Stop Obesity to national implementation: country progress on health system preparedness to scale up a comprehensive obesity chronic care programme.

The Lancet. Global health·2026

Related Experiment Video

Updated: Jun 17, 2025

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.0K

Ending Trans Fat-The First-Ever Global Elimination Program for a Noncommunicable Disease Risk Factor: JACC

Lindsay Steele1, Elizabeth Drummond1, Chizuru Nishida2

  • 1Resolve to Save Lives, New York, New York, USA.

Journal of the American College of Cardiology
|August 7, 2024
PubMed
Summary

Industrially produced trans fat (iTFA) elimination efforts have protected 3.2 billion people across 43 countries. Continued global action is needed to prevent hundreds of thousands of annual deaths from iTFA consumption.

Keywords:
REPLACEindustrial trans fatsnoncommunicable diseasespartially hydrogenated oilstrans fats

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.9K

Related Experiment Videos

Last Updated: Jun 17, 2025

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.0K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.9K

Area of Science:

  • Public Health
  • Food Science
  • Global Health Policy

Background:

  • Industrially produced trans fat (iTFA) is a harmful food additive replacing animal and saturated fats.
  • iTFA consumption is linked to an estimated 500,000 deaths annually worldwide.
  • iTFA is replaceable and its elimination is a key global health priority.

Purpose of the Study:

  • To assess the progress and impact of global initiatives aimed at eliminating industrially produced trans fat by 2023.
  • To highlight the role of policy interventions and corporate responsibility in achieving trans fat elimination.
  • To identify remaining challenges and propose strategies for complete global trans fat eradication.

Main Methods:

  • Review of global policies and regulations enacted since 2018.
  • Analysis of the reach and impact of the World Health Organization (WHO) REPLACE action package.
  • Assessment of corporate practices regarding the production and sale of trans fat-containing products.

Main Results:

  • 43 countries have adopted best-practice regulations, protecting 3.2 billion people.
  • Current policies are projected to prevent 66% of annual trans fat-related deaths.
  • Despite progress, companies continue to sell iTFA-containing products in unregulated markets.

Conclusions:

  • Accelerated global efforts have significantly advanced trans fat elimination, preventing substantial mortality.
  • Achieving complete global elimination requires sustained political will, robust accountability, and targeted regional policies.
  • Industry accountability and consumer protection in all markets are crucial for eradicating trans fat.